The market is segmented based on , By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe ) Industry Trends and Forecast to 2028.
.
The Europe Stem Cell Manufacturing Market size was valued at USD 11076.78 USD Million in 2020.
The Europe Stem Cell Manufacturing Market is projected to grow at a CAGR of 10.1% during the forecast period of 2021 to 2028.
The major players operating in the market include The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO.Ltd., VistaGen TherapeuticsInc., FUJIFILM Cellular DynamicsInc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyteInc., STEM CELL TechnologiesInc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., CatalentInc, Mesoblast Ltd, Astellas Pharma Inc. .
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.